An inhibitor of class I HDACs with IC50 values of 0.9, 0.9, 1.2, and >20 μM for recombinant human HDAC 1, 2, 3, and 8, respectively; displays a wide spectrum of antitumor activity, particularly in tumors normally refractory to conventional anticancer agents